Loading…

Predictive value of neutrophil-to-lymphocyte ratio for the fatality of COVID-19 patients complicated with cardiovascular diseases and/or risk factors

Previous studies have reported that a high neutrophil-to-lymphocyte ratio (NLR) is associated with disease severity and poor prognosis in COVID-19 patients. We aimed to investigate the clinical implications of NLR in patients with COVID-19 complicated with cardiovascular diseases and/or its risk fac...

Full description

Saved in:
Bibliographic Details
Published in:Scientific reports 2022-08, Vol.12 (1), p.13606-13606, Article 13606
Main Authors: Higaki, Akinori, Okayama, Hideki, Homma, Yoshito, Sano, Takahide, Kitai, Takeshi, Yonetsu, Taishi, Torii, Sho, Kohsaka, Shun, Kuroda, Shunsuke, Node, Koichi, Matsue, Yuya, Matsumoto, Shingo
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c517t-b0976ad0c9969076d925e7b8fc755d0e5f94c1360e72c948ef1f84d303070ce63
cites cdi_FETCH-LOGICAL-c517t-b0976ad0c9969076d925e7b8fc755d0e5f94c1360e72c948ef1f84d303070ce63
container_end_page 13606
container_issue 1
container_start_page 13606
container_title Scientific reports
container_volume 12
creator Higaki, Akinori
Okayama, Hideki
Homma, Yoshito
Sano, Takahide
Kitai, Takeshi
Yonetsu, Taishi
Torii, Sho
Kohsaka, Shun
Kuroda, Shunsuke
Node, Koichi
Matsue, Yuya
Matsumoto, Shingo
description Previous studies have reported that a high neutrophil-to-lymphocyte ratio (NLR) is associated with disease severity and poor prognosis in COVID-19 patients. We aimed to investigate the clinical implications of NLR in patients with COVID-19 complicated with cardiovascular diseases and/or its risk factors (CVDRF). In total, 601 patients with known NLR values were selected from the CLAVIS-COVID registry for analysis. Patients were categorized into quartiles (Q1, Q2, Q3, and Q4) according to baseline NLR values, and demographic and clinical parameters were compared between the groups. Survival analysis was conducted using the Kaplan–Meier method. The diagnostic performance of the baseline and follow-up NLR values was tested using receiver operating characteristic (ROC) curve analysis. Finally, two-dimensional mapping of patient characteristics was conducted using t-stochastic neighborhood embedding (t-SNE). In-hospital mortality significantly increased with an increase in the baseline NLR quartile (Q1 6.3%, Q2 11.0%, Q3 20.5%; and Q4, 26.6%; p 
doi_str_mv 10.1038/s41598-022-17567-4
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_68fb4951e1314a5aa7c710076ea02d2e</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_68fb4951e1314a5aa7c710076ea02d2e</doaj_id><sourcerecordid>2700451810</sourcerecordid><originalsourceid>FETCH-LOGICAL-c517t-b0976ad0c9969076d925e7b8fc755d0e5f94c1360e72c948ef1f84d303070ce63</originalsourceid><addsrcrecordid>eNp9ks2OFCEUhStG40zaeQFXJG7clMNvUWxMTPvXySTjQt0SGm5109JFCVSbfhDfV3p6oo4L2UDgnI_L5TTNc4JfEcz668yJUH2LKW2JFJ1s-aPmkmIuWsooffzX-qK5ynmH6xBUcaKeNhdMKN53WF42Pz8lcN4WfwB0MGEGFAc0wlxSnLY-tCW24bifttEeC6Bkio9oiAmVLaDBFBN8OZ4sy9uvq7ctUWiqEhhLRjbup-CtKeDQD1-2yJrkfDyYbOdgEnI-g8mQkRnddSUmn79VpC0x5WfNk8GEDFf386L58v7d5-XH9ub2w2r55qa1gsjSrrGSnXHYKtUpLDunqAC57gcrhXAYxKC4JazDIKmtL4aBDD13DDMssYWOLZrVmeui2ekp-b1JRx2N13cbMW20ScXbALrrhzVXggBhhBthjLSS4HopGEwdhcp6fWZN83oPztYmJBMeQB-ejH6rN_GgFes4w7wCXt4DUvw-Qy5677OFEMwIcc6aSkywrGJVpS_-ke7inMbaqpOqfjzpa0gWDT2rbIo5Jxh-F0OwPoVIn0Oka4j0XYj0qQp2NuUqHjeQ_qD_4_oFp47KTA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2700451810</pqid></control><display><type>article</type><title>Predictive value of neutrophil-to-lymphocyte ratio for the fatality of COVID-19 patients complicated with cardiovascular diseases and/or risk factors</title><source>Open Access: PubMed Central</source><source>Full-Text Journals in Chemistry (Open access)</source><source>ProQuest - Publicly Available Content Database</source><source>Coronavirus Research Database</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Higaki, Akinori ; Okayama, Hideki ; Homma, Yoshito ; Sano, Takahide ; Kitai, Takeshi ; Yonetsu, Taishi ; Torii, Sho ; Kohsaka, Shun ; Kuroda, Shunsuke ; Node, Koichi ; Matsue, Yuya ; Matsumoto, Shingo</creator><creatorcontrib>Higaki, Akinori ; Okayama, Hideki ; Homma, Yoshito ; Sano, Takahide ; Kitai, Takeshi ; Yonetsu, Taishi ; Torii, Sho ; Kohsaka, Shun ; Kuroda, Shunsuke ; Node, Koichi ; Matsue, Yuya ; Matsumoto, Shingo</creatorcontrib><description>Previous studies have reported that a high neutrophil-to-lymphocyte ratio (NLR) is associated with disease severity and poor prognosis in COVID-19 patients. We aimed to investigate the clinical implications of NLR in patients with COVID-19 complicated with cardiovascular diseases and/or its risk factors (CVDRF). In total, 601 patients with known NLR values were selected from the CLAVIS-COVID registry for analysis. Patients were categorized into quartiles (Q1, Q2, Q3, and Q4) according to baseline NLR values, and demographic and clinical parameters were compared between the groups. Survival analysis was conducted using the Kaplan–Meier method. The diagnostic performance of the baseline and follow-up NLR values was tested using receiver operating characteristic (ROC) curve analysis. Finally, two-dimensional mapping of patient characteristics was conducted using t-stochastic neighborhood embedding (t-SNE). In-hospital mortality significantly increased with an increase in the baseline NLR quartile (Q1 6.3%, Q2 11.0%, Q3 20.5%; and Q4, 26.6%; p &lt; 0.001). The cumulative mortality increased as the quartile of the baseline NLR increased. The paired log-rank test revealed significant differences in survival for Q1 vs. Q3 (p = 0.017), Q1 vs. Q4 (p &lt; 0.001), Q2 vs. Q3 (p = 0.034), and Q2 vs. Q4 (p &lt; 0.001). However, baseline NLR was not identified as an independent prognostic factor using a multivariate Cox proportional hazards regression model. The area under the curve for predicting in-hospital death based on baseline NLR was only 0.682, whereas that of follow-up NLR was 0.893. The two-dimensional patient map with t-SNE showed a cluster characterized by high mortality with high NLR at follow-up, but these did not necessarily overlap with the population with high NLR at baseline. NLR may have prognostic implications in hospitalized COVID-19 patients with CVDRF, but its significance depends on the timing of data collection.</description><identifier>ISSN: 2045-2322</identifier><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/s41598-022-17567-4</identifier><identifier>PMID: 35948607</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/250/255/2514 ; 692/4019/592/75 ; 692/499 ; Cardiovascular diseases ; Coronaviruses ; COVID-19 ; Data collection ; Embedding ; Humanities and Social Sciences ; Leukocytes (neutrophilic) ; Lymphocytes ; Medical prognosis ; Mortality ; multidisciplinary ; Neutrophils ; Patients ; Risk factors ; Science ; Science (multidisciplinary) ; Survival analysis</subject><ispartof>Scientific reports, 2022-08, Vol.12 (1), p.13606-13606, Article 13606</ispartof><rights>The Author(s) 2022</rights><rights>The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c517t-b0976ad0c9969076d925e7b8fc755d0e5f94c1360e72c948ef1f84d303070ce63</citedby><cites>FETCH-LOGICAL-c517t-b0976ad0c9969076d925e7b8fc755d0e5f94c1360e72c948ef1f84d303070ce63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2700451810?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2700451810?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,25734,27905,27906,36993,36994,38497,43876,44571,53772,53774,74161,74875</link.rule.ids></links><search><creatorcontrib>Higaki, Akinori</creatorcontrib><creatorcontrib>Okayama, Hideki</creatorcontrib><creatorcontrib>Homma, Yoshito</creatorcontrib><creatorcontrib>Sano, Takahide</creatorcontrib><creatorcontrib>Kitai, Takeshi</creatorcontrib><creatorcontrib>Yonetsu, Taishi</creatorcontrib><creatorcontrib>Torii, Sho</creatorcontrib><creatorcontrib>Kohsaka, Shun</creatorcontrib><creatorcontrib>Kuroda, Shunsuke</creatorcontrib><creatorcontrib>Node, Koichi</creatorcontrib><creatorcontrib>Matsue, Yuya</creatorcontrib><creatorcontrib>Matsumoto, Shingo</creatorcontrib><title>Predictive value of neutrophil-to-lymphocyte ratio for the fatality of COVID-19 patients complicated with cardiovascular diseases and/or risk factors</title><title>Scientific reports</title><addtitle>Sci Rep</addtitle><description>Previous studies have reported that a high neutrophil-to-lymphocyte ratio (NLR) is associated with disease severity and poor prognosis in COVID-19 patients. We aimed to investigate the clinical implications of NLR in patients with COVID-19 complicated with cardiovascular diseases and/or its risk factors (CVDRF). In total, 601 patients with known NLR values were selected from the CLAVIS-COVID registry for analysis. Patients were categorized into quartiles (Q1, Q2, Q3, and Q4) according to baseline NLR values, and demographic and clinical parameters were compared between the groups. Survival analysis was conducted using the Kaplan–Meier method. The diagnostic performance of the baseline and follow-up NLR values was tested using receiver operating characteristic (ROC) curve analysis. Finally, two-dimensional mapping of patient characteristics was conducted using t-stochastic neighborhood embedding (t-SNE). In-hospital mortality significantly increased with an increase in the baseline NLR quartile (Q1 6.3%, Q2 11.0%, Q3 20.5%; and Q4, 26.6%; p &lt; 0.001). The cumulative mortality increased as the quartile of the baseline NLR increased. The paired log-rank test revealed significant differences in survival for Q1 vs. Q3 (p = 0.017), Q1 vs. Q4 (p &lt; 0.001), Q2 vs. Q3 (p = 0.034), and Q2 vs. Q4 (p &lt; 0.001). However, baseline NLR was not identified as an independent prognostic factor using a multivariate Cox proportional hazards regression model. The area under the curve for predicting in-hospital death based on baseline NLR was only 0.682, whereas that of follow-up NLR was 0.893. The two-dimensional patient map with t-SNE showed a cluster characterized by high mortality with high NLR at follow-up, but these did not necessarily overlap with the population with high NLR at baseline. NLR may have prognostic implications in hospitalized COVID-19 patients with CVDRF, but its significance depends on the timing of data collection.</description><subject>631/250/255/2514</subject><subject>692/4019/592/75</subject><subject>692/499</subject><subject>Cardiovascular diseases</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Data collection</subject><subject>Embedding</subject><subject>Humanities and Social Sciences</subject><subject>Leukocytes (neutrophilic)</subject><subject>Lymphocytes</subject><subject>Medical prognosis</subject><subject>Mortality</subject><subject>multidisciplinary</subject><subject>Neutrophils</subject><subject>Patients</subject><subject>Risk factors</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>Survival analysis</subject><issn>2045-2322</issn><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9ks2OFCEUhStG40zaeQFXJG7clMNvUWxMTPvXySTjQt0SGm5109JFCVSbfhDfV3p6oo4L2UDgnI_L5TTNc4JfEcz668yJUH2LKW2JFJ1s-aPmkmIuWsooffzX-qK5ynmH6xBUcaKeNhdMKN53WF42Pz8lcN4WfwB0MGEGFAc0wlxSnLY-tCW24bifttEeC6Bkio9oiAmVLaDBFBN8OZ4sy9uvq7ctUWiqEhhLRjbup-CtKeDQD1-2yJrkfDyYbOdgEnI-g8mQkRnddSUmn79VpC0x5WfNk8GEDFf386L58v7d5-XH9ub2w2r55qa1gsjSrrGSnXHYKtUpLDunqAC57gcrhXAYxKC4JazDIKmtL4aBDD13DDMssYWOLZrVmeui2ekp-b1JRx2N13cbMW20ScXbALrrhzVXggBhhBthjLSS4HopGEwdhcp6fWZN83oPztYmJBMeQB-ejH6rN_GgFes4w7wCXt4DUvw-Qy5677OFEMwIcc6aSkywrGJVpS_-ke7inMbaqpOqfjzpa0gWDT2rbIo5Jxh-F0OwPoVIn0Oka4j0XYj0qQp2NuUqHjeQ_qD_4_oFp47KTA</recordid><startdate>20220810</startdate><enddate>20220810</enddate><creator>Higaki, Akinori</creator><creator>Okayama, Hideki</creator><creator>Homma, Yoshito</creator><creator>Sano, Takahide</creator><creator>Kitai, Takeshi</creator><creator>Yonetsu, Taishi</creator><creator>Torii, Sho</creator><creator>Kohsaka, Shun</creator><creator>Kuroda, Shunsuke</creator><creator>Node, Koichi</creator><creator>Matsue, Yuya</creator><creator>Matsumoto, Shingo</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><general>Nature Portfolio</general><scope>C6C</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20220810</creationdate><title>Predictive value of neutrophil-to-lymphocyte ratio for the fatality of COVID-19 patients complicated with cardiovascular diseases and/or risk factors</title><author>Higaki, Akinori ; Okayama, Hideki ; Homma, Yoshito ; Sano, Takahide ; Kitai, Takeshi ; Yonetsu, Taishi ; Torii, Sho ; Kohsaka, Shun ; Kuroda, Shunsuke ; Node, Koichi ; Matsue, Yuya ; Matsumoto, Shingo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c517t-b0976ad0c9969076d925e7b8fc755d0e5f94c1360e72c948ef1f84d303070ce63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>631/250/255/2514</topic><topic>692/4019/592/75</topic><topic>692/499</topic><topic>Cardiovascular diseases</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Data collection</topic><topic>Embedding</topic><topic>Humanities and Social Sciences</topic><topic>Leukocytes (neutrophilic)</topic><topic>Lymphocytes</topic><topic>Medical prognosis</topic><topic>Mortality</topic><topic>multidisciplinary</topic><topic>Neutrophils</topic><topic>Patients</topic><topic>Risk factors</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>Survival analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Higaki, Akinori</creatorcontrib><creatorcontrib>Okayama, Hideki</creatorcontrib><creatorcontrib>Homma, Yoshito</creatorcontrib><creatorcontrib>Sano, Takahide</creatorcontrib><creatorcontrib>Kitai, Takeshi</creatorcontrib><creatorcontrib>Yonetsu, Taishi</creatorcontrib><creatorcontrib>Torii, Sho</creatorcontrib><creatorcontrib>Kohsaka, Shun</creatorcontrib><creatorcontrib>Kuroda, Shunsuke</creatorcontrib><creatorcontrib>Node, Koichi</creatorcontrib><creatorcontrib>Matsue, Yuya</creatorcontrib><creatorcontrib>Matsumoto, Shingo</creatorcontrib><collection>SpringerOpen</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Science Journals</collection><collection>Biological Science Database</collection><collection>ProQuest - Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Higaki, Akinori</au><au>Okayama, Hideki</au><au>Homma, Yoshito</au><au>Sano, Takahide</au><au>Kitai, Takeshi</au><au>Yonetsu, Taishi</au><au>Torii, Sho</au><au>Kohsaka, Shun</au><au>Kuroda, Shunsuke</au><au>Node, Koichi</au><au>Matsue, Yuya</au><au>Matsumoto, Shingo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predictive value of neutrophil-to-lymphocyte ratio for the fatality of COVID-19 patients complicated with cardiovascular diseases and/or risk factors</atitle><jtitle>Scientific reports</jtitle><stitle>Sci Rep</stitle><date>2022-08-10</date><risdate>2022</risdate><volume>12</volume><issue>1</issue><spage>13606</spage><epage>13606</epage><pages>13606-13606</pages><artnum>13606</artnum><issn>2045-2322</issn><eissn>2045-2322</eissn><abstract>Previous studies have reported that a high neutrophil-to-lymphocyte ratio (NLR) is associated with disease severity and poor prognosis in COVID-19 patients. We aimed to investigate the clinical implications of NLR in patients with COVID-19 complicated with cardiovascular diseases and/or its risk factors (CVDRF). In total, 601 patients with known NLR values were selected from the CLAVIS-COVID registry for analysis. Patients were categorized into quartiles (Q1, Q2, Q3, and Q4) according to baseline NLR values, and demographic and clinical parameters were compared between the groups. Survival analysis was conducted using the Kaplan–Meier method. The diagnostic performance of the baseline and follow-up NLR values was tested using receiver operating characteristic (ROC) curve analysis. Finally, two-dimensional mapping of patient characteristics was conducted using t-stochastic neighborhood embedding (t-SNE). In-hospital mortality significantly increased with an increase in the baseline NLR quartile (Q1 6.3%, Q2 11.0%, Q3 20.5%; and Q4, 26.6%; p &lt; 0.001). The cumulative mortality increased as the quartile of the baseline NLR increased. The paired log-rank test revealed significant differences in survival for Q1 vs. Q3 (p = 0.017), Q1 vs. Q4 (p &lt; 0.001), Q2 vs. Q3 (p = 0.034), and Q2 vs. Q4 (p &lt; 0.001). However, baseline NLR was not identified as an independent prognostic factor using a multivariate Cox proportional hazards regression model. The area under the curve for predicting in-hospital death based on baseline NLR was only 0.682, whereas that of follow-up NLR was 0.893. The two-dimensional patient map with t-SNE showed a cluster characterized by high mortality with high NLR at follow-up, but these did not necessarily overlap with the population with high NLR at baseline. NLR may have prognostic implications in hospitalized COVID-19 patients with CVDRF, but its significance depends on the timing of data collection.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>35948607</pmid><doi>10.1038/s41598-022-17567-4</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2045-2322
ispartof Scientific reports, 2022-08, Vol.12 (1), p.13606-13606, Article 13606
issn 2045-2322
2045-2322
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_68fb4951e1314a5aa7c710076ea02d2e
source Open Access: PubMed Central; Full-Text Journals in Chemistry (Open access); ProQuest - Publicly Available Content Database; Coronavirus Research Database; Springer Nature - nature.com Journals - Fully Open Access
subjects 631/250/255/2514
692/4019/592/75
692/499
Cardiovascular diseases
Coronaviruses
COVID-19
Data collection
Embedding
Humanities and Social Sciences
Leukocytes (neutrophilic)
Lymphocytes
Medical prognosis
Mortality
multidisciplinary
Neutrophils
Patients
Risk factors
Science
Science (multidisciplinary)
Survival analysis
title Predictive value of neutrophil-to-lymphocyte ratio for the fatality of COVID-19 patients complicated with cardiovascular diseases and/or risk factors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T13%3A22%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predictive%20value%20of%20neutrophil-to-lymphocyte%20ratio%20for%20the%20fatality%20of%20COVID-19%20patients%20complicated%20with%20cardiovascular%20diseases%20and/or%20risk%20factors&rft.jtitle=Scientific%20reports&rft.au=Higaki,%20Akinori&rft.date=2022-08-10&rft.volume=12&rft.issue=1&rft.spage=13606&rft.epage=13606&rft.pages=13606-13606&rft.artnum=13606&rft.issn=2045-2322&rft.eissn=2045-2322&rft_id=info:doi/10.1038/s41598-022-17567-4&rft_dat=%3Cproquest_doaj_%3E2700451810%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c517t-b0976ad0c9969076d925e7b8fc755d0e5f94c1360e72c948ef1f84d303070ce63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2700451810&rft_id=info:pmid/35948607&rfr_iscdi=true